Multiparametric MRI and other imaging methods suitable to stage prostate carcinoma

• Authors: Michał Osuchowski , David Aebisher , Sabina Galiniak , Dorota Bartusik-Aebisher , Ewa Kaznowska
• Languages of publication: EN

Abstracts

EN

Introduction. The role of multiparametric magnetic resonance imaging (mpMRI) in staging prostate carcinoma has been increasing over the last years. It’s high sensitivity is indispensable when diagnosing this disease. It is a very accurate imaging method that helps the physician choose the best treatment method for his patient. Aim. Assessment of mpMRI which uses both anatomic and functional imaging techniques as a method to diagnose prostatic lesions. Advantages and disadvantages of staging prostate carcinoma with the use of biparametric MRI (bpMRI). Methods. The literature search was performed. Results. MpMRI can be used in pre-operative staging of prostate cancer. The technique is accurate in diagnosing and assessment of prostate carcinoma with Gleason Score (GS) of 7 and above. It is also recommended when planning a second biopsy of the prostatic gland.

Keywords

EN

Prostate cancer; multiparametric MRI (mpMRI) biparametric MRI (bpMRI); staging

• Publisher: Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
• Journal: European Journal of Clinical and Experimental Medicine
• Year: 2019
• Issue: 4
• Pages: 331-333

Contributors

author

Michał Osuchowski

• Clinical Department of Pathomorphology, Clinical Hospital No. 1, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

author

David Aebisher

• Department of Photomedicine and Physical Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

author

Sabina Galiniak

• Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

author

Dorota Bartusik-Aebisher

• Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

author

Ewa Kaznowska

• Clinical Department of Pathomorphology, Clinical Hospital No. 1, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

Identifiers

DOI

10.15584/ejcem.2019.4.7